Use of obinutuzumab for refractory autoimmune thrombocytopenia secondary to CLL
| Published in: | eJHaem |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-07-01
|
| Online Access: | https://doi.org/10.1002/jha2.78 |